Charles M Alexander Selected Research

Hemoglobins (Hemoglobin)

1/2009

Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles M Alexander Research Topics

Disease

8	Type 2 Diabetes Mellitus (MODY) 03/2015 - 03/2003
4	Hypoglycemia (Reactive Hypoglycemia) 06/2019 - 05/2009
4	Coronary Disease (Coronary Heart Disease) 05/2006 - 01/2004
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2006 - 03/2003
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 06/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 06/2019
2	Hyperglycemia 01/2021 - 06/2019
2	Body Weight (Weight, Body) 06/2019 - 01/2009
2	Heart Failure 03/2015 - 01/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2009 - 12/2006
2	Hyperlipidemias (Hyperlipidemia) 05/2006 - 12/2003
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2004 - 04/2003
1	Ketosis 01/2021
1	Osteoporosis 11/2009
1	Dyslipidemias (Dyslipidemia) 11/2009
1	Chronic Disease (Chronic Diseases) 11/2009
1	Asthma (Bronchial Asthma) 11/2009
1	Weight Loss (Weight Reduction) 01/2009
1	Weight Gain 01/2009
1	Diabetes Mellitus 12/2006
1	Myocardial Infarction 12/2006
1	Heart Diseases (Heart Disease) 07/2005
1	Hypertension (High Blood Pressure) 04/2005
1	Obesity 04/2005
1	Albuminuria 11/2004
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2003

Drug/Important Bio-Agent (IBA)

6	LipidsIBA 11/2009 - 04/2003
5	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 12/2006
4	Insulin (Novolin)FDA Link 01/2021 - 01/2006
4	Hypoglycemic Agents (Hypoglycemics)IBA 03/2015 - 01/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2006 - 07/2005
3	Losartan (Cozaar)FDA LinkGeneric 01/2006 - 03/2003
3	Angiotensin IIIBA 01/2006 - 03/2003
3	Antihypertensive Agents (Antihypertensives)IBA 01/2006 - 03/2003
3	CholesterolIBA 07/2005 - 05/2003
2	Sodium-Glucose Transport ProteinsIBA 01/2021 - 06/2019
2	Blood Glucose (Blood Sugar)IBA 06/2019 - 05/2009
2	Metformin (Glucophage)FDA LinkGeneric 01/2009 - 05/2005
2	HDL CholesterolIBA 04/2005 - 05/2003
1	KetonesIBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2019
1	Diphosphonates (Bisphosphonates)IBA 11/2009
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2009
1	Hemoglobins (Hemoglobin)IBA 01/2009
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2009
1	LDL CholesterolIBA 12/2006
1	oxidized low density lipoproteinIBA 12/2003
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2003
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2003
1	CreatinineIBA 03/2003

Therapy/Procedure

7	Therapeutics 01/2021 - 03/2003
1	Off-Label Use 01/2021
1	Glycemic Control 05/2005
1	Transplantation 12/2004
1	Renal Dialysis (Hemodialysis) 12/2004